The complex ecosystem of solid tumors has long challenged our understanding of cancer biology and treatment. Mass cytometry has emerged as a powerful tool to dissect this intricate microenvironment, offering unprecedented insights into the cellular composition and interactions within tumors. Let’s explore how this technology revolutionizes our understanding of solid tumor biology.
Characterizing Immune Infiltrates
Mass cytometry has dramatically enhanced our ability to characterize tumors’ diverse immune cell populations. The high-dimensional nature of the data allows for the identification of rare and novel cell subsets that may play crucial roles in tumor progression or response to therapy.
- Chevrier et al. (2017) in Cell, “An Immune Atlas of Clear Cell Renal Cell Carcinoma,” used a merged 73-marker CyTOF panel to create a comprehensive map of the immune landscape in renal cell carcinoma. This study revealed unexpected immune cell populations and their spatial distributions, providing new insights into tumor-immune interactions.
- Lavin et al. (2017) in Cell, “Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses,” employed CyTOF to profile early-stage lung tumors, uncovering a unique immune signature that could predict patient outcomes. This work demonstrated the power of mass cytometry in identifying prognostic immune markers in early-stage cancers.
Restricted content
You must be logged in and have a valid subscription to see this content. Please visit our subscription page for more info. If you are already a VIP member, be sure you are logged in with the same email address you made your purchase.
In the whirlwind world of tumor research, we stumbled upon a cellular superhero: the TAI cells. As we reported in our paper, "PD-L1 blockade engages tumor-infiltrating lymphocytes to co-express targetable activating and inhibitory receptors" (Beyrend et al., 2019), these T cells Activated and Inhibitory were quite the discovery. The name TAI was a stroke of bilingual brilliance. You see, I did my PhD in the Netherlands, where "taai" means "tough" or "tenacious". And these cells? They wore that name like a badge of honor. Our paper showed that these TAI cells, co-expressing both activating and inhibitory receptors, were the immune system's elite force against cancer. It was like discovering that some T cells had been secretly training for the cellular equivalent of the Olympics. So there you have it – TAI cells, the tough cookies of the immune world, proving that in science, a great discovery can also come with a great name. Who said research can't have a sense of humor?
